Core Viewpoint - The company, Wuxi Xinjie Electric Co., Ltd., is implementing a differentiated dividend distribution for the fiscal year 2024, which involves a cash dividend of 0.87 RMB per share for shareholders, excluding shares repurchased for employee stock ownership plans [1][2][4]. Group 1: Reasons for Differentiated Dividend - The differentiated dividend is a result of the company's share repurchase plan, which allows for the repurchased shares to not participate in profit distribution [1][2]. - The company plans to repurchase shares using its own funds, with a total repurchase amount between 25 million RMB and 40 million RMB, at a price not exceeding 56.73 RMB per share [1][2]. Group 2: Dividend Distribution Plan - The total share capital for the dividend distribution is 157,138,633 shares, with 272,443 shares repurchased and excluded from the distribution, resulting in a base of 156,866,190 shares for the cash dividend calculation [2][3]. - The total cash dividend to be distributed amounts to approximately 136,473,585.30 RMB [2][3]. Group 3: Calculation Basis for Differentiated Dividend - The ex-dividend reference price is calculated based on the formula: (previous closing price - cash dividend per share) / (1 + change in circulating shares ratio) [3]. - The actual cash dividend received by participating shareholders is 0.87 RMB per share, leading to an ex-dividend reference price of 61.04 RMB per share [3][4]. Group 4: Sponsor Institution's Review Opinion - The sponsor institution, Zhongtai Securities, has reviewed the differentiated dividend matter and found no violations of relevant laws and regulations, confirming that it does not harm the interests of the company or its shareholders [4].

金深法意字2025第 244 号 致：深圳市杰普特光电股份有限公司 北京金诚同达（深圳）律师事务所（以下简称"本所"）接受深圳市杰普特 光电股份有限公司（以下简称"公司"）委托，并根据《中华人民共和国公司法》 （以下简称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券 法》"）、《上市公司股份回购规则》《上海证券交易所上市公司自律监管指引 第 7 号——回购股份》（以下简称"《7 号指引》"）等法律、法规、规范性文 件以及《深圳市杰普特光电股份有限公司章程》（以下简称"《公司章程》"） 的有关规定，对公司 2024 年年度利润分配所涉及的差异化分红（以下简称"本 次差异化分红"）相关事项进行了核查，并出具本法律意见书。 为出具本法律意见书，本所律师审查了与本次差异化分红相关的文件和资 料，就相关事项向公司进行了必要的询问。公司已向本所保证，公司向本所提供 的文件及所作的陈述是真实、准确、完整、有效的，一切足以影响本法律意见书 的事实和文件均已向本所披露、提供，不存在隐瞒、虚假和遗漏，上述文件原件 及其签字、盖章是真实有效的，文件的复印件、影印件、扫描件、副本与原件、 正本一致。 北京金诚同达（深圳 ...

浙江天册律师事务所 关于 浙江梅轮电梯股份有限公司 差异化分红事项之 专项法律意见书 浙江省杭州市杭大路 1 号黄龙世纪广场 A 座 11 楼 310007 电话：0571-87901111 传真：0571-87901500 http://www.tclawfirm.com 编号：TCFGZY2025H0017 号 致：浙江梅轮电梯股份有限公司 浙江天册律师事务所（以下简称"本所"）接受浙江梅轮电梯股份有限公司（以 下简称"梅轮电梯"或"公司"）的委托，根据《中华人民共和国公司法》（以下简 称"《公司法》"）、《中华人民共和国证券法》（以下简称"《证券法》"）、《上 市公司股份回购规则》、《上海证券交易所股票上市规则》及《上海证券交易所上市 公司自律监管指引第7号—回购股份》（以下简称"《监管指引》"）等法律、法规 及规范性文件的相关规定，按照律师行业公认的业务标准、道德规范和勤勉尽责精神， 就公司本次2024年度利润分配所涉及的差异化分红（以下简称"本次差异化分红"） 相关事项出具本法律意见书。 第一部分 声明事项 本所及经办律师依据《证券法》 《律师事务所从事证券法律业务管理办法》和《律 师事务所证券法律 ...

Core Viewpoint - The legal opinion letter confirms that the differentiated dividend distribution plan of Duolun Technology Co., Ltd. complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [4][7]. Group 1: Differentiated Dividend Application - On February 19, 2020, the board of directors approved a plan to repurchase shares through centralized bidding on the Shanghai Stock Exchange, with a total repurchase fund of no less than RMB 30 million and no more than RMB 60 million, at a maximum price of RMB 10 per share, within a six-month implementation period [4][5]. - As of August 19, 2020, the company completed the share repurchase plan, acquiring a total of 4,000,000 shares, which accounted for a certain percentage of the total share capital [5]. Group 2: Differentiated Dividend Plan - On May 28, 2021, the annual general meeting approved a cash dividend distribution of RMB 0.05 per share (tax included) to all shareholders, with a total share capital of 25,000,131 shares, excluding 4,990,000 shares that do not participate in the profit distribution [5][6]. - The actual number of shares participating in the distribution is 20,940,131 shares, leading to a total cash dividend distribution calculation based on the remaining shares [6]. Group 3: Impact on Share Price - The actual ex-dividend reference price is calculated as (previous closing price - cash dividend) / (1 + change in circulating shares), resulting in an ex-dividend reference price of approximately RMB 8.05 per share [6]. - The impact of the differentiated dividend distribution on the ex-dividend reference price is minimal, with an absolute value of impact below 1% [7]. Group 4: Legal Compliance - The legal opinion asserts that the differentiated dividend distribution aligns with the Company Law, Securities Law, Repurchase Rules, and other relevant regulations, confirming no detriment to the interests of the company and its shareholders [7].

华泰联合证券有限责任公司 关于北京英诺特生物技术股份有限公司 差异化分红事项的核查意见 华泰联合证券有限责任公司（以下简称"华泰联合证券"或"保荐机构"）作为 北京英诺特生物技术股份有限公司（以下简称"英诺特"或"公司"）首次公开发行 股票并在科创板上市的保荐机构，根据《证券发行上市保荐业务管理办法》、 《上 海证券交易所科创板股票上市规则》及《上海证券交易所科创板上市公司自律监 管指引第 1 号——规范运作》等相关规定，对英诺特差异化分红送转特殊除权除 息（以下简称"本次差异化分红"）的事项进行了审慎核查，具体情况如下： 一、本次差异化分红的原因 以集中竞价交易方式回购公司股份方案的议案》，同意公司以自有资金通过上海 证券交易所交易系统以集中竞价交易方式回购公司股份，在未来适宜时机拟用于 员工持股计划或股权激励。公司拟用于本次回购的资金总额不低于人民币 5,000 万元（含），不超过人民币 10,000 万元（含），回购价格为不超过人民币 50 元/股 （含），回购股份的实施期限自董事会审议通过本次回购方案之日起 12 个月内。 具体内容详见公司分别于 2024 年 8 月 3 日、2024 年 8 月 8 ...

国浩律师（重庆）事务所 关于 神驰机电股份有限公司 差异化分红事项 之法律意见书 中国重庆市江北区江北城西大街 25 号平安财富中心 8 楼 邮编：400023 电话/Tel: +8623 8679 8588 6775 8383 传真/Fax: +8623 8679 8722 网址/Website: http://www.grandall.com.cn 二〇二五年五月 法律意见书 国浩律师（重庆）事务所 关于神驰机电股份有限公司 差异化分红事项 之法律意见书 致：神驰机电股份有限公司 国浩律师（重庆）事务所（以下简称"本所"）系经重庆市司法局批准成立的 法律服务执业机构，持有重庆市司法局颁发的《律师事务所执业许可证》。现本所 接受神驰机电股份有限公司（以下简称"公司"）的委托，根据《中华人民共和国 公司法》（以下简称"《公司法》"）《中华人民共和国证券法》（以下简称"《证 券法》"）《上海证券交易所交易规则》（以下简称"《交易规则》"）《上市公 司股份回购规则》（以下简称"《回购规则》"）《上海证券交易所上市公司自律 监管指引第 7 号—回购股份》（以下简称"《自律监管指引第 7 号》"）等有关法 律、法规、 ...

Group 1 - The core viewpoint of the article is that Lingyun Optical Technology Co., Ltd. is implementing a differentiated dividend distribution plan due to its share repurchase activities, which affects the total number of shares eligible for profit distribution [1][6] Group 2 - The reason for the differentiated dividend distribution is linked to the company's share repurchase, which involved a total expenditure of approximately 59.99 million yuan for repurchasing 2,563,582 shares, accounting for 0.5444% of the total share capital [1][2] - The company has completed the cancellation of repurchased shares, reducing its total share capital from 463,500,000 shares to 460,976,733 shares, and the registered capital decreased correspondingly [2] - The differentiated dividend plan involves distributing a cash dividend of 0.25 yuan per 10 shares (including tax) to shareholders, without capital reserve conversion or bonus shares [3][4] Group 3 - The calculation for the ex-dividend price is based on the formula: Ex-dividend reference price = (Previous closing price - Cash dividend) / (1 + Change in circulating shares ratio), with the actual cash dividend per share being approximately 0.0247 yuan [4][5] - The impact of the differentiated dividend on the ex-dividend reference price is minimal, with an absolute value of impact below 1% [5] Group 4 - The sponsor institution, China International Capital Corporation, confirms that the differentiated dividend distribution complies with relevant regulations and does not harm the interests of the company or its shareholders [6]

以上内容为证券之星据公开信息整理，由AI算法生成（网信算备310104345710301240019号），不构成 投资建议。 公司公告汇总：诚意药业每股现金红利0.25元，差异化分红方案实施 公司公告汇总：股权登记日为2025年6月17日，现金红利发放日为2025年6月18日 公司公告汇总：公司总股本327304320股，扣除已回购股份9618796股，实际参与分配的股本总数 为317685524股 A股每股现金红利0.25元。 股权登记日为2025年6月17日，除权（息）日及现金红利发放日均为2025年6月18日。 差异化分红送转：是。 分配方案经公司2025年5月20日的2024年年度股东大会审议通过。 发放年度为2024年年度，分派对象为截至股权登记日下午上海证券交易所收市后在中国结算上海 分公司登记在册的本公司全体股东，但存放于回购专用证券账户的股份不参与利润分配。 差异化分红方案为每10股派发现金红利人民币2.50元（含税）。 公司总股本327304320股，扣除已回购股份9618796股，实际参与分配的股本总数为317685524股， 合计拟派发现金红利79421381元（含税）。 除公司存放于回 ...

Core Viewpoint - Aohua Endoscopy (688212) has experienced a decline in stock price, closing at 52.72 yuan, down 5.65% from the previous week, with a current market capitalization of 7.1 billion yuan [1] Company Announcements - Aohua Endoscopy announced a cash dividend of 0.08 yuan per share (before tax), with the record date set for June 17, 2025, and the ex-dividend date and payment date on June 18, 2025 [1] - The total number of shares eligible for the dividend distribution is 132,166,179 shares, with a total cash dividend amounting to approximately 10.57 million yuan (before tax) [1] - The company has implemented a differentiated dividend distribution due to the repurchased shares not being entitled to profit distribution rights [2] Share Buyback - Aohua Endoscopy's board approved a share buyback plan on January 3, 2025, with a total buyback fund not less than 100 million yuan and not exceeding 200 million yuan [2] - As of April 30, 2025, the company has repurchased 2,499,071 shares, which are excluded from the profit distribution [2]

Core Viewpoint - The legal opinion issued by Shanghai Guangfa Law Firm confirms that Changzhou Tenglong Automotive Parts Co., Ltd.'s differentiated dividend distribution plan for 2024 complies with relevant laws and regulations, ensuring no harm to the interests of the company and its shareholders [7]. Group 1: Differentiated Dividend Distribution - The company plans to implement a differentiated dividend distribution for the 2024 fiscal year, with a cash dividend of 0.16 yuan per share (including tax) for shareholders [4][6]. - The total number of shares eligible for profit distribution is 485,499,266 shares, after excluding 5,300,040 shares repurchased and held in a special account [5][6]. - The company will not conduct a capital reserve transfer to increase share capital, and any changes in total share capital will be announced separately [4][5]. Group 2: Legal Compliance and Verification - The law firm conducted necessary verifications and confirmed that all documents and statements provided by the company were complete, truthful, and effective [2]. - The legal opinion is intended solely for the purpose of the differentiated dividend distribution and may be disclosed to the public alongside other required announcements [2][3]. - The opinion concludes that the differentiated dividend distribution aligns with the Company Law, Securities Law, and self-regulatory guidelines, with no adverse effects on the company or shareholders [7].